Chair-bound Exergaming in Pre-frail/ Frail Older Adults in Nursing Home
NCT ID: NCT06849557
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-04-07
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of a Tele-health Program
NCT05267444
Home-based Psychoeducation for Older Adults With Frailty: A Randomised Controlled Trial
NCT06415604
Dual-task Training to Prevent Cognitive Decline in Community-dwelling Older Adults: A Pilot Pragmatic RCT
NCT06648707
VR Motor-cognitive Training for Cognitive Frailty
NCT04467216
The Effects of Intelligent Intervention Programs on Hospitalized Elderly People With Frailty.
NCT06875024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents.
Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes.
All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control.
1. Intervention group (exergaming group, ERG) Those allocated to the ERG will receive supervised chair-bound exercise programme for 12 weeks.
2. Control group (wait list control, CG) Those allocated to the CG will receive supervised chair-bound exercise programme for 12 weeks after post-assessment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wait-list Control
Wait list control, after post-test, 12 week supervised exercise intervention
No interventions assigned to this group
Exergaming
12-week exergaming intervention
Exergaming
This intervention will last 12 weeks. Frail/ pre-frail participants will engage in supervised chair-bound exergaming.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exergaming
This intervention will last 12 weeks. Frail/ pre-frail participants will engage in supervised chair-bound exergaming.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pre-frail or frail according to the Fried Frailty Phenotypes;
* ability to understand and execute instructions; and
* ability to sit unassisted on a chair or in a wheelchair.
Exclusion Criteria
* any conditions that hinder the participation of intervention and assessment; and
* being involved in any other clinical trials.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hong Kong Metropolitan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hiu Kwong (Tak Yue) Nursing Centre
Kowloon, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Leung
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE-SF2024/58
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.